Relation of uric acid to serum levels of high-sensitivity c-reactive protein, triglycerides, and high-density lipoprotein cholesterol and to hepatic steatosis

American Journal of Cardiology

Volumn 110, Issue 12, 2012, Pages 1787-1792

  Keenan, Tanya ^a   Blaha, Michael J ^a   Nasir, Khurram ^a,b   Silverman, Michael G ^a   Tota Maharaj, Rajesh ^a   Carvalho, Jose A M ^c   Conceição, Raquel D ^c   Blumenthal, Roger S ^a   Santos, Raul D ^c,d  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b Center for Prevention and Wellness   (United States)

^c HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BODY MASS; CARDIAC PATIENT; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL EVALUATION; CORRELATIONAL STUDY; DIET RESTRICTION; DYSLIPIDEMIA; FATTY LIVER; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INFLAMMATION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; ULTRASOUND; URIC ACID BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHOLESTEROL, HDL; FATTY LIVER; FEMALE; HUMANS; LINEAR MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; TRIGLYCERIDES; URIC ACID; YOUNG ADULT;

EID: 84870289648     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.08.012     Document Type: Article

References (26)

1. D.I. Feig, D.H. Kang, R.J. Johnson Uric acid and cardiovascular risk N Engl J Med 359 2008 1811 1821
2. A.C. Gagliardi, M.H. Miname, R.D. Santos Uric acid: a marker of increased cardiovascular risk Atherosclerosis 202 2009 11 17
3. S.Y. Kim, J.P. Guevara, K.M. Kim, H.K. Choi, D.F. Heitjan, D.A. Albert Hyperuricemia and coronary heart disease: a systematic review and meta-analysis Arthritis Care Res (Hoboken) 62 2010 170 180
4. S.Y. Kim, J.P. Guevara, K.M. Kim, H.K. Choi, D.F. Heitjan, D.A. Albert Hyperuricemia and risk of stroke: a systematic review and meta-analysis Arthritis Rheum 61 2009 885 892
5. M. Saito, T. Ishimitsu, J. Minami, H. Ono, M. Ohrui, H. Matsuoka Relations of plasma high-sensitivity C-reactive protein to traditional cardiovascular risk factors Atherosclerosis 167 2003 73 79
6. T. Lyngdoh, P. Marques-Vidal, F. Paccaud, M. Preisig, G. Waeber, M. Bochud, P. Vollenweider Elevated serum uric acid is associated with high circulating inflammatory cytokines in the population-based COLAUS study PLoS ONE 6 2011 e19901
7. K.A. Bradley, A.F. DeBenedetti, R.J. Volk, E.C. Williams, D. Frank, D.R. Kivlahan AUDIT-C as a brief screen for alcohol misuse in primary care Alcohol Clin Exp Res 31 2007 1208 1217
8. C.L. Craig, A.L. Marshall, M. Sjöström, A.E. Bauman, M.L. Booth, B.E. Ainsworth, M. Pratt, U. Ekelund, A. Yngve, J.F. Sallis, P. Oja International physical activity questionnaire: 12-country reliability and validity Med Sci Sports Exerc 35 2003 1381 1395
9. D. Perloff, C. Grim, J. Flack, E.D. Frohlich, M. Hill, M. McDonald, B.Z. Morgenstern Human blood pressure determination by sphygmomanometry Circulation 88 1993 2460 2470
10. 2 Am J Kidney Dis 56 2010 486 495
11. K.G. Alberti, P. Zimmet, J. Shaw IDF Epidemiology Task Force Consensus Group The metabolic syndrome - a new worldwide definition Lancet 366 2005 1059 1062
12. D.I. Buckley, R. Fu, M. Freeman, K. Rogers, M. Helfand C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task Force Ann Intern Med 151 2009 483 495
13. T. McLaughlin, F. Abbasi, K. Cheal, J. Chu, C. Lamendola, G. Reaven Use of metabolic markers to identify overweight individuals who are insulin resistant Ann Intern Med 139 2003 802 809
14. S.J. Kim-Dorner, P.A. Deuster, S.A. Zeno, A.T. Remaley, M. Poth Should triglycerides and the triglycerides to high-density lipoprotein cholesterol ratio be used as surrogates for insulin resistance? Metabolism 59 2010 299 304
15. S. Saadeh, Z.M. Younossi, E.M. Remer, T. Gramlich, J.P. Ong, M. Hurley, K.D. Mullen, J.N. Cooper, M.J. Sheridan The utility of radiological imaging in nonalcoholic fatty liver disease Gastroenterology 123 2002 745 750
16. S. Bellentani, G. Saccoccio, F. Masutti, L.S. Crocè, G. Brandi, F. Sasso, G. Cristanini, C. Tiribelli Prevalence of and risk factors for hepatic steatosis in northern Italy Ann Intern Med 132 2000 112 117
17. K. Lee Relationship between uric acid and hepatic steatosis among Koreans Diabetes Metab 35 2009 447 451
18. Y.J. Lee, H.R. Lee, J.H. Lee, Y.H. Shin, J.Y. Shim Association between serum uric acid and non-alcoholic fatty liver disease in Korean adults Clin Chem Lab Med 48 2010 175 180
19. W. Baldwin, S. McRae, G. Marek, D. Wymer, V. Pannu, C. Baylis, R.J. Johnson, Y.Y. Sautin Hyperuricemia as a mediator of the proinflammatory endocrine imbalance in the adipose tissue in a murine model of the metabolic syndrome Diabetes 60 2011 1258 1269
20. R.J. Johnson, M.A. Lanaspa, E.A. Gaucher Uric acid: a danger signal from the RNA world that may have a role in the epidemic of obesity, metabolic syndrome, and cardiorenal disease: evolutionary considerations Semin Nephrol 31 2011 394 399
21. H. Lee, Y.J. Lee, H. Choi, E.H. Ko, J.W. Kim Reactive oxygen species facilitate adipocyte differentiation by accelerating mitotic clonal expansion J Biol Chem 284 2009 10601 10609
22. S. Furukawa, T. Fujita, M. Shimabukuro, M. Iwaki, Y. Yamada, Y. Nakajima, O. Nakayama, M. Makishima, M. Matsuda, I. Shimomura Increased oxidative stress in obesity and its impact on metabolic syndrome J Clin Invest 114 2004 1752 1761
23. T. Nakagawa, H. Hu, S. Zharikov, K.R. Tuttle, R.A. Short, O. Glushakova, X. Ouyang, D.I. Feig, E.R. Block, J. Herrera-Acosta, J.M. Patel, R.J. Johnson A causal role for uric acid in fructose-induced metabolic syndrome Am J Physiol Renal Physiol 290 2006 F625 F631
24. L.G. Sánchez-Lozada, E. Tapia, P. Bautista-García, V. Soto, C. Avila-Casado, I.P. Vega-Campos, T. Nakagawa, L. Zhao, M. Franco, R.J. Johnson Effects of febuxostat on metabolic and renal alterations in rats with fructose-induced metabolic syndrome Am J Physiol Renal Physiol 294 2008 F710 F718
25. J.D. Browning, J.D. Horton Molecular mediators of hepatic steatosis and liver injury J Clin Invest 114 2004 147 152
26. P. Angulo Nonalcoholic fatty liver disease N Engl J Med 346 2002 1221 1231